ROLE OF СD14 AND CYTOKINE GENE POLYMORPHISM IN CLINICAL FEATURES AND OUTCOMES OF NOSOCOMIAL PNEUMONIA
https://doi.org/10.15789/1563-0625-2008-4-5-467-472
Abstract
Abstract. This article is devoted to analysis of gene polymorphisms affecting CD14 regulatory molecule, as well as IL-1β, TNFα cytokines and IL-1RN in the patients with nosocomial pneumonias. The influence of single-nucleotide substitution polymorphisms is discussed in terms of clinical severity and outcomes of nosocomial pneumonia. A predisposition for more severe clinical course of pneumonia is revealed in a group of patients with C/Т and Т/Т genotypes of CD14 regulatory molecule. A carriership of –511*Т аllele in the patients’ genotype predisposed for reduced terms of pneumonia evolution, like as development of acute respiratory distress syndrome and more pronounced acute phase response (leukocytosis and high levels of C-reactive protein). IL-RN*2 allele was associated with generally poor outcome, whereas presence of –308 (AG, AA) variant of TNFα polymorphic gene was connected with pulmonary and extrapulmonary complications of nosocomial pneumonia. (Med. Immunol., vol. 10, N 4-5, pp 467-472).
About the Authors
E. A. Baygosina
Государственное учреждение здравоохранения Омской области «Областная клиническая больница», г. Омск
Russian Federation
Russian Federation
V. I. Sovalkin
Омская государственная медицинская академия
Russian Federation
Russian Federation
References
1. Громова А.Ю., Кабанова В.И., Казаков А.А. Влияние полиморфизма генов IL-1β и IL-1Ra на эффективность терапии рекомбинантным IL-1β (Беталейкин) больных хроническим вирусным гепатитом С // Цитокины и воспаление. – 2004. – Т. 3, № 1. – С. 17-25.
2. Имангулова М.М., Бикмаева А.Р., Хуснутдинова Э.К. Полиморфизм кластера гена интерлейкина 1 у больных туберкулезом легких // Цитокины и воспаление. – 2005. – Т. 4, № 1. – С. 36-41.
3. Маркелова Е.В., Гельцер Б.И., Корявченкова И.В., Костюшко Ф.В. Состояние системы цитокинов при нозокомиальных пневмониях // Цитокины и воспаление. – 2003. – Т. 2, № 1. – С. 14-19.
4. Рыдловская А.В., Симбирцев А.С. Функциональный полиморфизм гена TNFA и патология // Цитокины и воспаление. – 2005. – Т. 4, № 3. – С. 4-10.
5. Симбирцев А.С., Громова А.Ю. Функциональный полиморфизм генов регуляторных молекул воспаления // Цитокины и воспаление. – 2005. – Т. 4, № 1. – С. 3-10.
6. Agnese D.M., Calvano J.E., Hahm S.J. Human toll-like receptor 4 mutation but not CD14 polymorphisms are associated with an increased risk of gram-negative infections // J. Infect. Dis. – 2002. – Vol. 186. – P. 1522-1525.
7. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia // Am. J. Respir. Crit. Care Med. – 2005. – Vol. 171. – P. 388-416.
8. Baldini M. A polymorphism in the 5’ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E // Am. Respir. Cell Mol. Biol. – 1999. – Vol. 20. – P. 976-983.
9. Da Silva Correia J., Soldau K., Christen U. Lipopolysaccharide is in close proximity to each of the protein in its membrane receptor complex: transfer from CD14 to TLR4 and MD2 // J. Biol. Chem. – 2001. – Vol. 276. – P. 21129-21135.
10. 1Eng H.L., Chen C.H., Kuo С.С., Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection // J. Infect. Dis. – 2003. – Vol. 188. – P. 90-97.
11. Gibot S., Cariou A., Drouet L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate // Crit. Care Med. – 2002. – Vol. 30. – P. 969-973.
12. Heesen M., Bloemeke B., Obertacke U. The – 260 C → T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients // Intensive Care Med. – 2002. – Vol. 28. – P. 1161-1163.
13. Heijamans B.T., Westendorp R.G., Droog S. Tumor necrosis factor alpha-308 polymorphisms associated woith increased sepsis mortality in ventilated very low birth weight infants // Pediatr. Infect. Dis. J. – 2004. – Vol. 23, N 5.– P. 424-428.
14. Hubacek J.A., Pit’ha J., Skodova Z. C (–260) → T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction // Circulation. – 1999. – Vol. 99. – P. 3218-3220.
15. Karhukorpi J., Yan Y., Niemela S. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14 // Clin. Exp. Immunol. – 2002. – Vol. 128. – P. 326-332.
16. Knapp S., Wieland C.W., Florquin S. Differential roles of CD14 and toll-like receptor 4 and 2 in murine Acinetobacter pneumonia // Am. J. Respir. Crit. Care Med. – 2006. – Vol. 173. – P. 122-129.
17. Santilla S. Presence of the IL-1 RA allele 2 (IL-1RN*2) is associated with enhanced IL-1b production in vitro // Scand. J. Immunol. – 1998. – Vol. 47. – P. 195-198.
18. Wright S.D., Ramos R.A., Tobias P.S. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein // Science. – 1990. – Vol. 249. – P. 1431-1433.
Review
For citations:
Baygosina E.A., Sovalkin V.I. ROLE OF СD14 AND CYTOKINE GENE POLYMORPHISM IN CLINICAL FEATURES AND OUTCOMES OF NOSOCOMIAL PNEUMONIA. Medical Immunology (Russia). 2008;10(4-5):467-472. (In Russ.) https://doi.org/10.15789/1563-0625-2008-4-5-467-472
Views:
814
Email this article 